Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Robert Marcus
Oct 4, 2021

Related news

Jun 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Heart of AI

Nov 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Investment Into Biosciences Boomed, Could The Bubble Burst?

Dec 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI drug discovery platform raises Series B funding

Mar 26
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

VC Firms Have Long Backed AI. Now, They Are Using It.

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

How data is helping European VCs find their next hidden gems

Nov 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Our Relationship with AI: Friend Or Foe? Summary of our Global Study

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

How data is helping European VCs find their next hidden gems

Dec 10
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Biotech investors cap off record year in fundraising

Dec 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analysts compile top European biotech news of 2021

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie